Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of psychiatric research"
DOI: 10.1016/j.jpsychires.2019.05.020
Abstract: This study evaluated the efficacy and safety/tolerability of quetiapine extended-release 300 mg/day (QUEXR300), quetiapine immediate-release 600 mg/day (QUEIR600), and quetiapine immediate-release 300 mg/day (QUEIR300) formulations for treating bipolar depression. A random-effect network meta-analysis of 8-week, double-blind, randomized placebo-controlled…
read more here.
Keywords:
depression;
quetiapine immediate;
group;
placebo group ... See more keywords